Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfront
Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfront
Body unavailable. Use the original source.
Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfront
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.